在肌缩侧面硬化症中使用CNM-Au8:HEALEY ALS平台试验
, James D Berry1, Nicholas J Maragakis2
1Sean M. Healey and AMG Center for ALS and the Neurological Clinical Research Institute, Massachusetts General Hospital, Harvard Medical School, Boston.
JAMA
|March 11, 2025
概括
在临床试验中,CNM- Au8在减缓肌缩侧面硬化 (ALS) 疾病进展方面没有显著的益处. 需要进一步的研究来探索它在ALS治疗中的潜力.
科学领域:
- 神经科学
- 生物化学
- 纳米技术
背景情况:
- 肌缩侧面硬化 (ALS) 是一种与生物能量衰竭相关的进展性神经退行性疾病.
- CNM-Au8是一种金纳米晶悬浮剂,通过催化NAD+再生来增强细胞ATP的产生.
- 这种机制表明对像ALS这样的神经退行性疾病有潜在的治疗益处.
研究的目的:
- 评估CNM- Au8对改变ALS进展的疗效.
- 评估ALS患者使用CNM-Au8的安全性和耐受性.
主要方法:
- 一个2/3阶段,多中心,随机,双盲平台试验 (HEALEY ALS试验) 涉及161名参与者.
- 参与者接受了CNM- Au8 (每天60毫克或30毫克) 或安慰剂24周.
- 主要疗效终点:使用贝叶斯功能和生存的共享参数模型 (疾病率比率 - DRR) 改变ALS疾病的严重程度.
主要成果:
- 主要分析显示,CNM- Au8和安慰剂组之间的疾病率比率 (DRR) 没有显著差异 (DRR,0. 97;95% CI,0. 783-1. 175).
- 二级终点,包括功能评估和存活率,也表明CNM- Au8治疗没有益处.
- 在CNM- Au8组中常见的不良反应包括腹和恶心;在安慰剂组中,疲劳和肌肉虚弱更为频繁.
结论:
- 在24周内,CNM- Au8在减缓ALS疾病进展方面没有显著的益处.
- 这项研究表明,在这种ALS队列中,CNM- Au8治疗没有显著的益处或危害.
- 可能需要进一步研究CNM-Au8在ALS或其他神经退行性疾病中的作用.
更多相关视频
07:00Eye-Tracking Control to Assess Cognitive Functions in Patients with Amyotrophic Lateral Sclerosis
Published on: October 13, 2016
8.1K
11:52Establishment of an Electrophysiological Platform for Modeling ALS with Regionally-Specific Human Pluripotent Stem Cell-Derived Astrocytes and Neurons
Published on: August 26, 2021
2.2K
相关概念视频
Satellite Stem Cells and Muscular Dystrophy
2.6K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.6K
Clinical Trials
11.2K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
11.2K
Parkinson's Disease: Treatment
1.4K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.4K
Alzheimer's Disease: Treatment
1.2K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.2K
